| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |